🔗 Share this article

An underground market for unlicensed weight-loss medications is being driven by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.

Experimental Drug Gaining Popularity Online

The experimental drug, which remains in research studies, is being promoted by online personalities for its supposed fat-burning effects. Viewers are urged to contact these accounts directly for source information, while also receiving promotional offers.

Thriving Commerce on Messaging Platforms

Additionally, a flourishing trade exists on Telegram, where groups with thousands of participants share comparison photos, administration instructions and assertions of next-day UK delivery. Sellers market the drug there before directing customers to other platforms for transactions.

Learning About Retatrutide

This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could assist patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being promoted online as the successor to Ozempic.

Healthcare Experts Voice Concerns

However, doctors and chemists have cautions that the sale of what is still an unapproved medication in the UK is worrisome and could lead to individuals injecting products of uncertain source.

Some professionals stated the demand for retatrutide could be linked to the rising price of licensed slimming products such as Mounjaro.

Regulatory Status and Implementation

Selling retatrutide on social media or Telegram is illegal in the UK, as it is an unlicensed medication that must not be marketed or distributed for human use under the Human Medicines Regulations 2012.

Some influencers attempt to circumvent the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and supply can still violate medicines, marketing, and consumer laws, potentially leading to penalties, prosecution or prison.

Service Response and Content Removal

Based on TikTok, the platform has taken down violative material and prohibited associated hashtags and query recommendations. The company said it was dedicated to keeping the platform secure and allocating resources in enhancing compliance measures.

Digital Trading Activities

Research also discovered groups with up to 9,000 participants selling retatrutide using Telegram's integrated discovery tool, which operates like a public directory. Typing “retatrutide” immediately displays groups with numerous of users, filled with photos of weight loss, glowing testimonials and step-by-step instructions for preparing or injecting at home.

Within moments of entering one community, a seller shared contact information, where most transactions take place. The vendor sent an instruction manual and promised shipping within 48 hours. When questioned whether the substance was authentic, one seller responded: “You can’t be sure.” Another shared a photo of a alleged testing documentation. None asked about body mass, health issues or past usage.

Product Details and Costs

Within these groups, messages display black plastic packages with Royal Mail labels, stating to contain new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, prepared at home with purified liquid, or ready-to-use injectors usually sold at £160 for 20 milligrams. When asked how long a injector should be used, vendors give conflicting answers ranging from a several days to “depends on your body”.

Service Moderation and Safety Measures

A spokesperson for Telegram stated it regularly monitored dangerous content on its service including material that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“People are injecting substances they can’t verify. Even if the research behind retatrutide is valid, these online versions may not contain what they claim,” said Jason Murphy, the director of pharmaceutical services at a pharmacy service.

A medical professional of an online medical service connected the surge in demand to recent cost increases for authorized weight-loss drugs such as Mounjaro. “With prices rising, individuals are turning to online platforms. But fake injections are highly dangerous. You cannot know what’s contained or whether the conditions they were produced in was clean,” she said.

Her team has already encountered patients injured by self-injection from unverified suppliers. “We recognize the disappointment, but purchasing from Telegram or communication platforms is taking chances with your well-being,” said Wyllie. “These substances could be impure or improperly measured.”

Manufacturer Statement

A spokesperson from Eli Lilly stated retatrutide was in phase 3 clinical trials and had not been reviewed or approved by any regulatory agency globally. “Therefore at this point no one can market [it] for human use,” they explained, noting that any item “falsely representing itself as a company experimental substance not yet approved … may subject patients to possibly significant health risks”.